Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Healius Ltd

HLS
Current price
1.34 AUD -0.27 AUD (-17.08%)
Last closed 1.57 AUD
ISIN AU0000033359
Sector Healthcare
Industry Diagnostics & Research
Exchange Australian Securities Exchange
Capitalization 1 170 798 183 AUD
Yield for 12 month -29.74 %
1Y
3Y
5Y
10Y
15Y
HLS
21.11.2021 - 28.11.2021

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics, QML Pathology, TML Pathology, Abbott Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories, medical centers, patient collection centers, and community imaging centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia. Address: 161 Castlereagh Street, Sydney, NSW, Australia, 2000

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2.41 AUD

P/E ratio

Dividend Yield

Current Year

+1 776 358 314 AUD

Last Year

+1 736 379 570 AUD

Current Quarter

+912 695 384 AUD

Last Quarter

+863 662 930 AUD

Current Year

+336 309 735 AUD

Last Year

+347 601 441 AUD

Current Quarter

+282 496 107 AUD

Last Quarter

+146 385 272 AUD

Key Figures HLS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 108 237 615 AUD
Operating Margin TTM 5.55 %
PE Ratio
Return On Assets TTM 1.23 %
PEG Ratio
Return On Equity TTM -49.94 %
Wall Street Target Price 2.41 AUD
Revenue TTM 1 776 358 379 AUD
Book Value 1.46 AUD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -1.7 %
Dividend Yield
Gross Profit TTM 563 873 218 AUD
Earnings per share -0.98 AUD
Diluted Eps TTM -0.98 AUD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 286.1 %
Profit Margin -36.98 %

Dividend Analytics HLS

Dividend growth over 5 years

Continuous growth

2 years

Payout Ratio 5 years average

61 %

Dividend History HLS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 07.09.2022
Forward Annual Dividend Yield
Last Split Factor 511:493
Payout Ratio
Last Split Date 22.08.2018
Dividend Date

Stock Valuation HLS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 166.6667
Enterprise Value Revenue 1.5398
Price Sales TTM 0.662
Enterprise Value EBITDA 10.137
Price Book MRQ 1.1059

Financials HLS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators HLS

For 52 weeks

1.1 AUD 1.89 AUD
50 Day MA 1.72 AUD
Shares Short Prior Month
200 Day MA 1.47 AUD
Short Ratio
Shares Short
Short Percent